194 related articles for article (PubMed ID: 2963615)
1. Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure.
Drexler H; Finkh M; Höing S; Toth M; Just H; Lang RE
Basic Res Cardiol; 1987; 82(6):517-29. PubMed ID: 2963615
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading.
Drexler H; Hänze J; Finckh M; Lu W; Just H; Lang RE
Circulation; 1989 Mar; 79(3):620-33. PubMed ID: 2521817
[TBL] [Abstract][Full Text] [Related]
3. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
[TBL] [Abstract][Full Text] [Related]
4. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure].
Indolfi C; Piscione F; Volpe M; Lembo G; De Campora P; Russolillo E; Ambrosini V; Condorelli M; Chiariello M
Cardiologia; 1991 May; 36(5):351-6. PubMed ID: 1836751
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of atrial peptide infusion in heart failure.
Crozier IG; Nicholls MG; Ikram H; Espiner EA; Gomez HJ; Warner NJ
Lancet; 1986 Nov; 2(8518):1242-5. PubMed ID: 2878131
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
[TBL] [Abstract][Full Text] [Related]
7. Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody.
Drexler H; Hirth C; Stasch HP; Lu W; Neuser D; Just H
Circ Res; 1990 May; 66(5):1371-80. PubMed ID: 2139823
[TBL] [Abstract][Full Text] [Related]
8. [Significance of atrial natriuretic peptide in heart failure: experimental findings].
Drexler H; Hirth C; Stasch JP; Lang RE; Finckh M; Maio G; Just H
Z Kardiol; 1988; 77 Suppl 2():47-50. PubMed ID: 2970172
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide levels during development of chronic heart failure after myocardial infarction in rats.
Lee RW; Gay RG; Moffett C; Johnson DG; Goldman S
Life Sci; 1987 May; 40(20):2025-30. PubMed ID: 2952858
[TBL] [Abstract][Full Text] [Related]
10. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
11. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.
Mizuno O; Onishi K; Dohi K; Motoyasu M; Okinaka T; Ito M; Isaka N; Nakano T
Am J Cardiol; 2001 Oct; 88(8):863-6. PubMed ID: 11676948
[TBL] [Abstract][Full Text] [Related]
12. Effects of adenosine infusion on renal function, plasma ANP and ADH concentrations and central hemodynamics in anesthetized pigs.
Elias AN; Wesley RC; Gordon IL; Pandian MR; Vaziri ND
Gen Pharmacol; 1997 Mar; 28(3):429-33. PubMed ID: 9068986
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
Pesonen A; Leppäluoto J; Ruskoaho H
J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
[TBL] [Abstract][Full Text] [Related]
14. Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure.
Raya TE; Lee RW; Westhoff T; Goldman S
Circulation; 1989 Dec; 80(6):1886-92. PubMed ID: 2532077
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide infusion in chronic heart failure in the rat.
Kohzuki M; Hodsman GP; Harrison RW; Western PS; Johnston CI
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S43-6. PubMed ID: 2473348
[TBL] [Abstract][Full Text] [Related]
17. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
18. Pressor hormones regulate atrial-stretch-induced release of atrial natriuretic peptide in the pithed rat.
Ruskoaho H; Vakkuri O; Arjamaa O; Vuolteenaho O; Leppäluoto J
Circ Res; 1989 Mar; 64(3):482-92. PubMed ID: 2563674
[TBL] [Abstract][Full Text] [Related]
19. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat.
Dunn BR; Ichikawa I; Pfeffer JM; Troy JL; Brenner BM
Circ Res; 1986 Sep; 59(3):237-46. PubMed ID: 2945668
[TBL] [Abstract][Full Text] [Related]
20. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
